| Income Statement | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Revenues | 34,098 | 33,773 | ||
| Research and development | 7,006 | 7,456 | ||
| Cost of sales | 34,555 | 34,597 | ||
| Interest expense, net | -1,849 | -1,708 | ||
| Changes in fair value of warrants and conversion option | 456 | -513 | ||
| Other (income) expense, net | 164 | 1,653 | ||
| Selling, general and administrative expenses | 12,292 | 10,155 | ||
| Net loss from continuing operations before income taxes | -21,896 | -17,977 | ||
| Income tax expense (benefit) | - | 6 | ||
| Net loss from continuing operations, net of income taxes | -21,896 | -17,983 | ||
| Net (loss) income from discontinued operations, net of income taxes (refer to note3, discontinued operations) | -1,040 | -1,717 | ||
| Net loss attributable to common stockholders | -22,936 | -19,700 | ||
| Basic eps | -4.14 | -3.58 | ||
| Diluted eps | -4.14 | -3.58 | ||
| Basic average shares | 5,544,000 | 5,496,000 | ||
| Diluted average shares | 5,544,000 | 5,496,000 | ||
null (BHIL)
null (BHIL)